FibroGen Stock 17.47% Up On Thursday
(VIANEWS) – The NASDAQ ended the session with FibroGen (FGEN) rising 17.47% to $0.54 on Thursday while NASDAQ slid 0.16% to $14,258.49. FibroGen’s last close was $0.46, 98.22% below its 52-week high of $25.69. About FibroGen FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. Its lead product…